Answer
There is insufficient evidence to exclude risk to the infant. Discuss treatment need, infant factors and breastfeeding benefits with the oncology team before deciding.
Sources for this answer
- NEULASTA Pre-Filled Syringeemc · SmPC Current selected SmPC · Version 5
- NHS Specialist Pharmacy ServiceNHS Specialist Pharmacy Service · NHS medicine guidance